Jibin A. Simon

Chennai, TN, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Impact of Vitamin D Deficiency on Ischemic Stroke Severity: Insights from a Prospective Study.

Impact of Vitamin D Deficiency on Ischemic Stroke Severity: Insights from a Prospective Study.

Journal: Cureus
Published: July 22, 2024

Tropical Co-infection in a Tertiary Care Center in South India: A Case Report.

Tropical Co-infection in a Tertiary Care Center in South India: A Case Report.

Journal: Cureus
Published: July 17, 2024

An Unusual Mimic of Axial Spondyloarthritis: A Case Report.

An Unusual Mimic of Axial Spondyloarthritis: A Case Report.

Journal: Cureus
Published: April 12, 2024

Evaluating Cardiovascular Risks: The Platelet Lymphocyte Ratio and the Neutrophil Lymphocyte Ratio As High-Risk Heart Score Predictors in Non-ST Elevation Myocardial Infarction (NSTEMI) and Unstable Angina Patients.

Evaluating Cardiovascular Risks: The Platelet Lymphocyte Ratio and the Neutrophil Lymphocyte Ratio As High-Risk Heart Score Predictors in Non-ST Elevation Myocardial Infarction (NSTEMI) and Unstable Angina Patients.

Journal: Cureus
Published: April 10, 2024

von Hippel-Lindau Syndrome and Secondary Hypertension: A Case Report.

von Hippel-Lindau Syndrome and Secondary Hypertension: A Case Report.

Journal: Cureus
Published: April 06, 2024

Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.

Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.

Journal: Annals of the rheumatic diseases
Published: September 30, 2020

Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study).

Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study).

Journal: Arthritis research & therapy
Published: June 03, 2014

Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.

Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: December 21, 2013
Showing 1-8 of 8

Last Updated: 09/26/2026